Pub Date : 2024-01-10DOI: 10.1007/s40521-023-00357-2
Sebastian Vigand Svendsen, Kristian F. Mose, C. Mortz
{"title":"Allergic Contact Dermatitis in Children: Clinical Management and Emerging Allergens","authors":"Sebastian Vigand Svendsen, Kristian F. Mose, C. Mortz","doi":"10.1007/s40521-023-00357-2","DOIUrl":"https://doi.org/10.1007/s40521-023-00357-2","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"77 14","pages":"1-15"},"PeriodicalIF":1.1,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139440762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.1007/s40521-023-00356-3
E. Zubeldia-Varela, Andrea Macías-Camero, M. Pérez-Gordo
{"title":"From Bacteria to Host: Deciphering the Impact of Sphingolipid Metabolism on Food Allergic Reactions","authors":"E. Zubeldia-Varela, Andrea Macías-Camero, M. Pérez-Gordo","doi":"10.1007/s40521-023-00356-3","DOIUrl":"https://doi.org/10.1007/s40521-023-00356-3","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"33 2","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139155756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"What is New in Alpha-Gal Syndrome?","authors":"Teresa Peralta, Gigia Roizen, Natalia Crisóstomo, Raquel Aguilera-Insunza","doi":"10.1007/s40521-023-00353-6","DOIUrl":"https://doi.org/10.1007/s40521-023-00353-6","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"5 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139248614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-18DOI: 10.1007/s40521-023-00351-8
P. Quan, Sergio Sánchez-Fernández, Lucía Parrado Gil, Alfonso Calvo Alonso, José Miguel Bodero Sánchez, Ana Ortega Eslava, Marta Luri, Gabriel Gastaminza Lasarte
{"title":"Usefulness of Drug Allergy Alert Systems: Present and Future","authors":"P. Quan, Sergio Sánchez-Fernández, Lucía Parrado Gil, Alfonso Calvo Alonso, José Miguel Bodero Sánchez, Ana Ortega Eslava, Marta Luri, Gabriel Gastaminza Lasarte","doi":"10.1007/s40521-023-00351-8","DOIUrl":"https://doi.org/10.1007/s40521-023-00351-8","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"57 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139261694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-11DOI: 10.1007/s40521-023-00340-x
Cesar Fireth Pozo-Beltran, Barbara Elizondo-Villarreal, Fernando Morett-Vera, Victor Gonzalez-Uribe, Roxana Minerva Rodriguez-Romo, Elsy Maureen Navarrete-Rodriguez, Jorge Andres Paniagua-Santos, Jesus Fernando Ledezma-Ortega, Adriana Virginia Briceño-Gamboa
{"title":"Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids","authors":"Cesar Fireth Pozo-Beltran, Barbara Elizondo-Villarreal, Fernando Morett-Vera, Victor Gonzalez-Uribe, Roxana Minerva Rodriguez-Romo, Elsy Maureen Navarrete-Rodriguez, Jorge Andres Paniagua-Santos, Jesus Fernando Ledezma-Ortega, Adriana Virginia Briceño-Gamboa","doi":"10.1007/s40521-023-00340-x","DOIUrl":"https://doi.org/10.1007/s40521-023-00340-x","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136209281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-29DOI: 10.1007/s40521-023-00350-9
Cristina Gomez-Casado, Zsofia Unger, Peter Olah, Bernhard Homey
{"title":"Microbiome in Atopic Dermatitis: Is It All About Staphylococcus aureus?","authors":"Cristina Gomez-Casado, Zsofia Unger, Peter Olah, Bernhard Homey","doi":"10.1007/s40521-023-00350-9","DOIUrl":"https://doi.org/10.1007/s40521-023-00350-9","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135200233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-28DOI: 10.1007/s40521-023-00348-3
Ira Finegold
{"title":"The Roots and Growth of Allergen Immunotherapy","authors":"Ira Finegold","doi":"10.1007/s40521-023-00348-3","DOIUrl":"https://doi.org/10.1007/s40521-023-00348-3","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"66 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135387142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-20DOI: 10.1007/s40521-023-00349-2
Tiago Azenha Rama, Mariana Castells
Opinion statement Mastocytosis is associated with a high risk of anaphylaxis, in part due to drug hypersensitivity reactions (DHR). Drugs associated with mast cell activation include nonsteroidal anti-inflammatory drugs (NSAIDs), drugs used in the perioperative setting, including general anesthetics, neuromuscular blocking agents (NMBAs) and opiates/opioids, radiocontrast media (RCM), vaccines, and antibiotics such as quinolones and vancomycin. To protect patients against DHR and anaphylaxis, general avoidance of potential drug triggers is common practice, which often deprives patients of important drugs at times of need and limits their options. We aimed to critically review current evidence on the indications to avoid drugs in children and adults with mastocytosis. Recent data shows that general avoidance of drugs with potential mast cell activation action is not indicated in all patients with mastocytosis, but guidelines are lacking. Drugs tolerated before and after the onset of mastocytosis should not be avoided and a personalized approach is recommended to address drugs inducing mast cell activation. Pre-medication (RCM, local and general anesthetics, vaccines), use of safer alternatives (opioids, NBMAs, NSAIDs in selected cases), and drug challenges (NSAIDs in most cases) are recommended to increase the safety of patients with mastocytosis when introduced to new drugs.
{"title":"Triggers of Anaphylaxis in Mastocytosis Patients: Evidence of the Current Drug-Avoidance Recommendation","authors":"Tiago Azenha Rama, Mariana Castells","doi":"10.1007/s40521-023-00349-2","DOIUrl":"https://doi.org/10.1007/s40521-023-00349-2","url":null,"abstract":"Opinion statement Mastocytosis is associated with a high risk of anaphylaxis, in part due to drug hypersensitivity reactions (DHR). Drugs associated with mast cell activation include nonsteroidal anti-inflammatory drugs (NSAIDs), drugs used in the perioperative setting, including general anesthetics, neuromuscular blocking agents (NMBAs) and opiates/opioids, radiocontrast media (RCM), vaccines, and antibiotics such as quinolones and vancomycin. To protect patients against DHR and anaphylaxis, general avoidance of potential drug triggers is common practice, which often deprives patients of important drugs at times of need and limits their options. We aimed to critically review current evidence on the indications to avoid drugs in children and adults with mastocytosis. Recent data shows that general avoidance of drugs with potential mast cell activation action is not indicated in all patients with mastocytosis, but guidelines are lacking. Drugs tolerated before and after the onset of mastocytosis should not be avoided and a personalized approach is recommended to address drugs inducing mast cell activation. Pre-medication (RCM, local and general anesthetics, vaccines), use of safer alternatives (opioids, NBMAs, NSAIDs in selected cases), and drug challenges (NSAIDs in most cases) are recommended to increase the safety of patients with mastocytosis when introduced to new drugs.","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136306959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-30DOI: 10.1007/s40521-023-00346-5
I. Bobolea, N. Rubira, J. Mullol
{"title":"Respiratory Exposure Tests in Aspirin Exacerbated Respiratory Disease","authors":"I. Bobolea, N. Rubira, J. Mullol","doi":"10.1007/s40521-023-00346-5","DOIUrl":"https://doi.org/10.1007/s40521-023-00346-5","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45999214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：